Research reportReversal of oxycodone and HYDROCODONE (cas 125-29-1) tolerance by diazepam
-
Add time:09/08/2019 Source:sciencedirect.com
The Centers for Disease Control has declared opioid abuse to be an epidemic. Overdose deaths are largely assumed to be the result of excessive opioid consumption. In many of these cases, however, opioid abusers are often polydrug abusers. Benzodiazepines are one of the most commonly co-abused substances and pose a significant risk to opioid users. In 2016, the FDA required boxed warnings – the FDA’s strongest warning – for prescription opioid analgesics and benzodiazepines about the serious risks associated with using these medications at the same time. The point of our studies was to evaluate the interactions between these two classes of drugs. We investigated whether diazepam adds to the depressant effects of opioids or do they alter the levels of tolerance to opioids. In the present study, we have found that the antinociceptive tolerance that developed to repeated administration of oxycodone was reversed by an acute dose of diazepam. Antinociceptive tolerance to HYDROCODONE (cas 125-29-1) was also reversed by acute injection of diazepam; however, a fourfold higher dose of diazepam was required when compared to reversal of oxycodone-induced tolerance. These doses of diazepam did not potentiate the acute antinociceptive effect of either opioid. The same dose of diazepam that reversed oxycodone antinociceptive tolerance also reversed oxycodone locomotor tolerance while having no potentiating effects. These studies show that diazepam does not potentiate the acute effect of prescription opioids but reverses the tolerance developed after chronic administration of the drugs.
We also recommend Trading Suppliers and Manufacturers of HYDROCODONE (cas 125-29-1). Pls Click Website Link as below: cas 125-29-1 suppliers
Prev:Short communicationEvaluation of urinary dihydrocodeine excretion in human by gas chromatography–mass spectrometry
Next:Short CommunicationPharmacokinetics of HYDROCODONE (cas 125-29-1) and hydromorphone after oral HYDROCODONE (cas 125-29-1) in healthy Greyhound dogs) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Pharmacology in Emergency MedicineDecreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of HYDROCODONE (cas 125-29-1)09/29/2019
- Anomalous observations of HYDROCODONE (cas 125-29-1) in patients on oxycodone09/28/2019
- Acetaminophen modulation of HYDROCODONE (cas 125-29-1) reward in rats10/01/2019
- HYDROCODONE (cas 125-29-1) in postoperative personalized pain management: Pro-drug or drug?09/27/2019
- Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of HYDROCODONE (cas 125-29-1) After Coadministration With a Single-entity, Once-daily, Extended-release HYDROCODONE (cas 125-29-1) Tablet09/26/2019
- Effects of ceftriaxone on HYDROCODONE (cas 125-29-1) seeking behavior and glial glutamate transporters in P rats09/25/2019
- Selected Topics: ToxicologyComparison of Unintentional Exposures to Codeine and HYDROCODONE (cas 125-29-1) Reported to Texas Poison Centers09/24/2019
- Postoperative opioid prescribing practices and the impact of the HYDROCODONE (cas 125-29-1) schedule change09/10/2019
- Short CommunicationPharmacokinetics of HYDROCODONE (cas 125-29-1) and hydromorphone after oral HYDROCODONE (cas 125-29-1) in healthy Greyhound dogs09/09/2019


